Onyx Pharmaceuticals Aktie
WKN: 900778 / ISIN: US6833991093
08.08.2013 23:31:03
|
Onyx Pharma Q2 Loss Narrows
(RTTNews) - Onyx Pharmaceuticals Inc. (ONXX) Thursday reported second-quarter net loss of $53.2 million or $0.73 per share, compared to loss of $106.0 million or $1.65 per share last year.
Adjusted loss for the quarter were $0.40 per share compared to $0.68 per share last year. On average, 16 analysts polled by Thomson Reuters expected the company to report a loss of $0.42 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues rose 110 percent to $153.0 million from $72.7 million last year. Analysts estimates revenues of $151.73 million for the quarter.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Onyx Pharmaceuticals Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |